Quintet Private Bank (Europe) S.A. Bristol Myers Squibb CO Transaction History
Quintet Private Bank (Europe) S.A.
- $1.72 Trillion
- Q2 2024
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 55,088 shares of BMY stock, worth $2.78 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
55,088
Previous 373,525
85.25%
Holding current value
$2.78 Million
Previous $22.8 Billion
88.54%
% of portfolio
0.15%
Previous 1.02%
Shares
7 transactions
Others Institutions Holding BMY
# of Institutions
2,478Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$9.39 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$8.2 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$4.62 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$4.48 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.54 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $107B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...